Forbes: How Johnson & Johnson Could Regain Public’s Trust In Vaccine Crisis
April 16, 2021
The decision to put the Johnson & Johnson Covid-19 vaccine on pause after six cases of blood clotting were linked to women who took the shot has forced the company to deal with yet another crisis situation. Get Managing Director Lindsay Singleton’s thoughts on how the pharma giant can weather the storm. Read more here.